Pricing

Intersect ENT Inc (XENT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Thomas A. West
Employees:
430
1555 ADAMS DRIVE, MENLO PARK, CA, 94025
650-641-2100

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus. PROPel Mini, a releasing implant for patients undergoing frontal sinus surgery, is a steroid-release implant. VENSure Navigable and Stand-alone balloon is used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available